Insider trade

CEO reported a gift or transfer of 25K HALO shares

Traded Nov 26, 2025 · Filed Dec 2, 2025

HalozymeHALO

25K
Shares

Why it stands out

Gift or transfer — classified separately from trades.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Nov 26, 2025
Reporting period: Not applicable
Filed with the SEC: Dec 2, 2025

CEOGift / transfer

Context

Classification

gift transfer

Code G — gift, bequest or transfer

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001159036-25-000063
Filed / recorded

Dec 2, 2025, 12:31 AM UTC

Added to OQRO

Oct 6, 2026, 7:59 PM UTC

Parser

form4-xml-v2

Data quality

Verified: identifiers matched exactly

Issuer

HALOZYME THERAPEUTICS, INC.

Issuer CIK

1159036

Ticker

HALO

Reporting person

Helen Torley

Relationship

Director, Officer

Officer title

PRESIDENT AND CEO

Security

Common Stock

Table

Non-derivative (Table I)

Transaction date

Nov 26, 2025

Transaction code

G

Shares / units

25,000

Price per share

$0.00

Acquired / disposed

Disposed (D)

Shares owned after

708,719

Ownership form

Direct

Amendment

No

Footnotes from the filing

Represents a bona fide gift to charity.

Around the same time

9,326Shares

10mo ago

Derivative exercise or conversion — not an open-market buy.

More Official record

Officer sold ~$278K of Halozyme

Automatic sale10mo ago

9,326Derivative units

10mo ago

Derivative exercise or conversion — not an open-market buy.

More Official record